No reduction seen in number of self-reported exacerbations treated with oral corticosteroids, antibiotics, or both
Some Children Prescribed Nonrecommended Meds for COVID-19
Some children were prescribed ineffective and potentially harmful medications for acute COVID-19
One in Seven Drug Supply Chain Issue Reports Tied to Drug Shortages
Supply disruptions increased for drugs with and without reports at the start of the COVID-19 pandemic
Cyberattack Stalls Prescription Dispensing at UnitedHealth
By Robin Foster HealthDay Reporter TUESDAY, Feb. 27, 2024 (HealthDay News) — For nearly a week, prescription drug orders have been disrupted at thousands of pharmacies as the largest health …
Risk Profile IDs COVID-19 Patients Who Will Benefit From Baricitinib
Baricitinib plus remdesivir linked to reduced risk of death, progression to invasive mechanical ventilation
Frexalimab Has Favorable Effect on Relapsing Multiple Sclerosis
Generally favorable effect seen in terms of number of new gadolinium-enhancing T1-weighted lesions at week 12
JNJ-77242113 Shows Greater Efficacy Than Placebo for Plaque Psoriasis
Percentage of patients with PASI-75 response was higher with the interleukin-23-receptor antagonist peptide
Meds Rarely Offered for COVID-19 Patients at High Risk for Progression
No reason other than mild symptoms given for almost half of patients at high risk for progression who were not offered treatment
Simnotrelvir Shortens Time to Resolution of Symptoms in COVID-19
On day 5, the decrease in viral load from baseline was greater in the simnotrelvir group versus placebo group
New Rx for Schedule-II Stimulants for ADHD Increased During Pandemic
No significant changes seen in new prescriptions for antidepressants, benzodiazepines, or buprenorphine for opioid use disorder